Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy

European Journal of Medical Research

Volumn 16, Issue 7, 2011, Pages 315-323

  Wilke, Michael H ^a   Grube, R F ^a   Bodmann, K F ^b  

^a Dr Wilke GmbH Inspiringhealth   (Germany)

^b Werner Forßmann Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; LINEZOLID; QUINOLONE DERIVATIVE; VANCOMYCIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFTAZIDIME; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; COST OF ILLNESS; FEMALE; GERMANY; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PRACTICE GUIDELINE; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; WARD; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; HOSPITAL ACQUIRED PNEUMONIA; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 80051695014     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-16-7-315     Document Type: Article

References (38)

1. DiCocco JM, Croce MA. Ventilator-associated pneumonia: an overview. Expert Opin Pharmacother. 2009 Jun;10(9):1461-7.
2. Ott E, Bange FC, Reichardt C, Graf K, Eckstein M, Schwab F, et al. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2010 Dec;76(4):300-3.
3. Amin A. Clinical and economic consequences of ventilator-associated pneumonia. Clin Infect Dis. 2009 Aug 15;49 Suppl 1:S36-43.
4. Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg. 2006 Apr;243(4):547-52.
5. Geffers C, Gastmeier P. Nosocomial Infections and Multidrug-resistant Organisms in Germany: Epidemiological Data From KISS (The Hospital Infection Surveillance System). Dtsch Arztebl Int. 2011 Feb;108(6):87-93.
6. van der Kooi TI, Mannien J, Wille JC, van Benthem BH. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. J Hosp Infect. 2010 Jul;75(3):168-72.
7. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010 Mar;38(2):95-104 e2.
8. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000 Sep;31 Suppl 4:S131-8.
9. Harmanci A, Harmanci O, Akova M. Hospital-acquired pneumonia: challenges and options for diagnosis and treatment. J Hosp Infect. 2002 Jul;51(3):160-7. (Pubitemid 38001886)
10. Mehta RM, Niederman MS. Nosocomial pneumonia. Curr Opin Infect Dis. 2002 Aug;15(4):387-94. (Pubitemid 34816427)
11. Hernandez G, Rico P, Diaz E, Rello J. Nosocomial lung infections in adult intensive care units. Microbes Infect. 2004 Sep;6(11):1004-14. (Pubitemid 39166043)
12. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005 Jul;51(4):171-6. (Pubitemid 41404694)
13. Torres A. The new American Thoracic Society/Infectious Disease Society of North America guidelines for the management of hospital-acquired, ventilator-associated and healthcare-associated pneumonia: a current view and new complementary information. Curr Opin Crit Care. 2006 Oct;12(5):444-5. (Pubitemid 44341710)
14. Bauer TT, Lorenz J, Bodmann KF, Vogel F. [Abbreviated guidelines for prevention, diagnostics, and therapy of nosocomial pneumonia]. Med Klin (Munich). 2005 Jun 15;100(6):355-60.
15. Bodmann KF. Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy. 2005 Aug; 51(5):227-33. (Pubitemid 41207041)
16. Niederman MS. Can guidelines for the treatment of respiratory infections lead to reduced rates of antibiotic resistance? Semin Respir Infect. 2001 Sep;16(3):203-9.
17. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol. 2008 Jan; 19(1):19-53. (Pubitemid 351547672)
18. Martinez R, Reyes S, Lorenzo MJ, Menendez R. Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med. 2009 Apr;30(2):172-8.
19. Wilke MH, Grube R. Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach. Eur J Med Res. 2010 Nov 30;15(12):564-70.
20. Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F, et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail. 2011 Apr;13(4):450-9.
21. Pretto M, Spirig R, Kaelin R, Muri-John V, Kressig RW, Suhm N. Outcomes of elderly hip fracture patients in the Swiss healthcare system: A survey prior to the implementation of DRGs and prior to the implementation of a Geriatric Fracture Centre. Swiss Med Wkly. 2010;140(140):w13086.
22. Lotter O, Dolderer J, Stahl S, Atzei A, Haerle M, Schaller HE. Comparison of Hand Surgery in the German and Italian DRG Systems. Gesundheitswesen. 2010 Sep 30; 30:30.
23. Gorenoi V, Dintsios CM, Schonermark MP, Hagen A. Intravascular brachytherapy for peripheral vascular disease. GMS Health Technol Assess. 2008;4(4):Doc08.
24. Wilke MH, Hocherl E, Scherer J, Janke L. [Introduction of the new DRG-based reimbursement system in German hospitals - a difficult operation? Experiences and possible solutions from the viewpoint of trauma surgery]. Unfallchirurg. 2001 May;104(5):372-9.
25. Flanders SA, Collard HR, Saint S. Nosocomial pneumonia: state of the science. Am J Infect Control. 2006 Mar; 34(2):84-93. (Pubitemid 43254576)
26. Abdel-Fattah MM. Nosocomial pneumonia: risk factors, rates and trends. East Mediterr Health J. 2008 May-Jun; 14(3):546-55.
27. Amaral SM, Cortes Ade Q, Pires FR. Nosocomial pneumonia: importance of the oral environment. J Bras Pneumol. 2009 Nov;35(11):1116-24.
28. Baughman RP. Nosocomial pneumonia: the gorilla in the ICU. J Intensive Care Med. 2003 Jul-Aug;18(4):227-8.
29. Ewig S, Gillissen A. [Diagnostic and therapeutic criteria for nosocomial pneumonia]. Med Klin (Munich). 2000 Sep 15;95(9):533-4.
30. Fabian TC. Empiric therapy for pneumonia in the surgical intensive care unit. Am J Surg. 2000 Feb;179(2A Suppl):18S-23S; discussion 4S-5S.
31. Fleming CA, Balaguera HU, Craven DE. Risk factors for nosocomial pneumonia. Focus on prophylaxis. Med Clin North Am. 2001 Nov;85(6):1545-63.
32. Pletz MW, Burkhardt O, Weite T. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy. Eur J Med Res. 2010 Nov 30;15(12):507-13.
33. Orrick JJ, Segal R, Johns TE, Russell W, Wang F, Yin DD. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines. Pharmacoeconomics. 2004;22(11):751-7. (Pubitemid 38998499)
34. Bird D, Zambuto A, O'Donnell C, Silva J, Korn C, Burke R, et al. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical intensive care unit. Arch Surg. 2010 May; 145(5):465-70.
35. Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther. 2010 Feb;32(2):293-9.
36. Koulenti D, Rello J. Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care. Expert Opin Pharmacother. 2006 Aug;7(12):1555-69.
37. Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilator-associated pneumonia: a review. Eur J Intern Med. 2010 Oct;21(5):360-8.
38. Kieninger AN, Lipsett PA. Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment. Surg Clin North Am. 2009 Apr;89(2):439-61, ix.